BioSurfaces Receives $1.72 Million Small Business Innovation Research (SBIR) Direct Phase II Grant
BioSurfaces Receives $1.72 Million Small Business Innovation Research (SBIR) Direct Phase II Grant from National Institutes of Health...
Week 6 – Epiphany
Hope all is going well. We hope that you enjoyed the webcast that Cam from our team put together regarding our 20-year anniversary. If...
NuSpun™ Vascular Graft Could Revolutionize Hemodialysis Access (Monthly Spin-Off #7)
Targeted Drug Delivery to Prevent Outflow Complications From Hemodialysis Access Grafts Background End-stage renal disease (ESRD) is a...
BioSurfaces 20th Anniversary (Webcast #7)
Join us on a thrilling journey through time as we unveil the remarkable story of BioSurfaces - from humble beginnings to groundbreaking...
Week 5 – Those Who Do Not Learn from History
Hope all is going well. April has been one of those months for me that has been busy but not as productive as you want it to be. ...
Biocompatibility: Key Considerations for Medical Devices (Monthly Spin-Off #6)
BIOCOMPATIBILITY TESTING – BENCHTOP EVALUATION OF A MATERIAL’S INTERACTION WITH THE BODY’S CELLS Biocompatibility Overview To gain FDA...
Week 4 – The Amazing Race – Business Owner Edition
Hope all is going well. I would like to start out this week’s blog by passing along our condolences to the family of one of our...
Next-Gen Cell Therapy Device (Monthly Spin-Off #5)
Bio-Spun™ Cell Chamber – Using the Body’s Normal Functions to Deliver a Targeted Therapy Overview Chronic disease is a broad term that is...
Week 3 – Why Use Bio-Spun™?
Hope all is going well. A lot has transpired since the last blog. It was a pretty busy February and March is shaping up to be even...
Monthly Spin-Off #4 (The Future of Drug Delivery)
Can Targeted Drug Delivery Help the Body Heal? Bio-Spun™ Materials Integrated with Drug Help Healing Medical Devices: Need and...
